Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Ampco-Pittsburgh
AP
$193M
| $1.25M | ﹤0.01% |
474,957
-7,462
| -2% | -$24.6K |
|
2152
Mueller Industries
MLI
$15.4B
| $1.25M | ﹤0.01% |
66,400
-120,000
| -64% | -$2.38M |
|
2153
Triple Flag Precious Metals
TFPM
$6.63B
| $1.24M | ﹤0.01% |
95,100
-53,100
| -36% | -$712K |
|
|
INZY
2154
DELISTED
Inozyme Pharma
INZY
| $1.24M | ﹤0.01% |
295,608
+56,408
| +24% | +$287K |
|
|
PRPH
2155
DELISTED
ProPhase Labs
PRPH
| $1.24M | ﹤0.01% |
28,401
-1,650
| -5% | -$96.6K |
|
2156
Peloton Interactive
PTON
$2.38B
| $1.24M | ﹤0.01% |
245,400
-3,441,000
| -93% | -$24.5M |
|
2157
Westamerica Bancorp
WABC
$1.37B
| $1.24M | ﹤0.01% |
28,631
-5,070
| -15% | -$227K |
|
2158
BK Technologies
BKTI
$292M
| $1.24M | ﹤0.01% |
99,482
+1,612
| +2% | +$20.5K |
|
|
LOVE
2159
LoveSac
LOVE
$252M
| $1.23M | ﹤0.01% |
61,800
-196,300
| -76% | -$4.84M |
|
2160
Urban One Class D
UONEK
$24.9M
| $1.23M | ﹤0.01% |
24,461
-419
| -2% | -$22.8K |
|
2161
Destination XL Group
DXLG
$32.6M
| $1.23M | ﹤0.01% |
274,024
+113,024
| +70% | +$530K |
|
2162
Atara Biotherapeutics
ATRA
$74.3M
| $1.23M | ﹤0.01% |
33,164
-51,512
| -61% | -$2.29M |
|
2163
Reading International Class A
RDI
$35.2M
| $1.23M | ﹤0.01% |
578,990
-8,300
| -1% | -$20.3K |
|
|
DOYU
2164
DouYu International Holdings
DOYU
$137M
| $1.22M | ﹤0.01% |
125,600
-36,443
| -22% | -$382K |
|
2165
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.96B
| $1.22M | ﹤0.01% |
+27,000
| New | +$1.25M |
|
2166
Rigel Pharmaceuticals
RIGL
$733M
| $1.22M | ﹤0.01% |
113,183
-44,930
| -28% | -$541K |
|
2167
Relay Therapeutics
RLAY
$4.3B
| $1.22M | ﹤0.01% |
+144,700
| New | +$1.56M |
|
2168
AC Immune
ACIU
$236M
| $1.21M | ﹤0.01% |
425,179
+7,200
| +2% | +$21.9K |
|
2169
GFL Environmental
GFL
$15B
| $1.21M | ﹤0.01% |
+38,100
| New | +$1.31M |
|
|
AVNS
2170
DELISTED
Avanos Medical
AVNS
| $1.21M | ﹤0.01% |
59,868
+41,668
| +229% | +$945K |
|
2171
Sabra Healthcare REIT
SBRA
$5.34B
| $1.21M | ﹤0.01% |
+86,900
| New | +$1.11M |
|
2172
Holley
HLLY
$362M
| $1.21M | ﹤0.01% |
+242,500
| New | +$1.37M |
|
2173
Twin Disc
TWIN
$337M
| $1.21M | ﹤0.01% |
88,193
+17,700
| +25% | +$229K |
|
|
SUPV
2174
Grupo Supervielle
SUPV
$763M
| $1.21M | ﹤0.01% |
544,701
+172,632
| +46% | +$495K |
|
2175
Oak Valley Bancorp
OVLY
$280M
| $1.21M | ﹤0.01% |
48,129
+6,056
| +14% | +$157K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 713 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.